Blue Buffalo Pet Products Inc. (NASDAQ:BUFF)‘s stock had its “buy” rating reiterated by analysts at Susquehanna in a report released on Tuesday. They presently have a $29.00 price objective on the stock. Susquehanna’s price target would indicate a potential upside of 19.98% from the company’s previous close.

Other analysts also recently issued research reports about the company. Wedbush reiterated a “neutral” rating and set a $25.00 price target (up previously from $24.00) on shares of Blue Buffalo Pet Products in a research report on Wednesday, August 10th. Zacks Investment Research cut Blue Buffalo Pet Products from a “buy” rating to a “hold” rating in a report on Tuesday, September 6th. JPMorgan Chase & Co. raised their price objective on Blue Buffalo Pet Products from $28.00 to $33.00 and gave the company an “overweight” rating in a report on Thursday, August 11th. DA Davidson reissued a “buy” rating and set a $29.00 price objective on shares of Blue Buffalo Pet Products in a report on Monday. Finally, Deutsche Bank AG raised their price objective on Blue Buffalo Pet Products from $28.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, August 11th. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $29.50.

Analyst Recommendations for Blue Buffalo Pet Products (NASDAQ:BUFF)

Shares of Blue Buffalo Pet Products (NASDAQ:BUFF) traded down 0.41% during mid-day trading on Tuesday, reaching $24.07. The company had a trading volume of 94,032 shares. The firm has a market capitalization of $4.73 billion, a PE ratio of 43.76 and a beta of 2.27. The stock has a 50 day moving average price of $24.56 and a 200 day moving average price of $25.14. Blue Buffalo Pet Products has a 12-month low of $15.19 and a 12-month high of $27.50.

Blue Buffalo Pet Products (NASDAQ:BUFF) last issued its quarterly earnings results on Wednesday, August 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.17 by $0.02. The firm earned $286.85 million during the quarter, compared to the consensus estimate of $281.90 million. Blue Buffalo Pet Products had a return on equity of 406.20% and a net margin of 10.14%. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities analysts forecast that Blue Buffalo Pet Products will post $0.76 earnings per share for the current year.

In other Blue Buffalo Pet Products news, CEO Kurt Schmidt sold 50,000 shares of Blue Buffalo Pet Products stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $24.83, for a total value of $1,241,500.00. Following the transaction, the chief executive officer now directly owns 103,571 shares of the company’s stock, valued at approximately $2,571,667.93. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director L.P. Invus sold 12,512,124 shares of the business’s stock in a transaction that occurred on Friday, September 16th. The shares were sold at an average price of $24.83, for a total value of $310,676,038.92. The disclosure for this sale can be found here. 10.30% of the stock is owned by company insiders.

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Blue Buffalo Pet Products by 94.0% in the second quarter. Vanguard Group Inc. now owns 5,299,211 shares of the company’s stock valued at $123,683,000 after buying an additional 2,567,667 shares during the period. Bank of New York Mellon Corp boosted its position in Blue Buffalo Pet Products by 1,664.1% in the second quarter. Bank of New York Mellon Corp now owns 1,886,140 shares of the company’s stock valued at $44,021,000 after buying an additional 1,779,224 shares during the period. American Century Companies Inc. acquired a new position in Blue Buffalo Pet Products during the second quarter valued at about $38,618,000. BlackRock Institutional Trust Company N.A. boosted its position in Blue Buffalo Pet Products by 68.0% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 2,439,087 shares of the company’s stock valued at $57,953,000 after buying an additional 987,288 shares during the period. Finally, Boston Advisors LLC acquired a new position in Blue Buffalo Pet Products during the third quarter valued at about $10,526,000. 90.39% of the stock is currently owned by hedge funds and other institutional investors.

About Blue Buffalo Pet Products

Blue Buffalo Pet Products, Inc (BBPP) is a holding company. The Company, through its subsidiaries, develops, produces, markets and sells pet food under the BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Natural Veterinary Diet lines. Blue Buffalo Company, Ltd. (Blue), Blue Buffalo Import Mexico, S.

5 Day Chart for NASDAQ:BUFF

Receive News & Stock Ratings for Blue Buffalo Pet Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Buffalo Pet Products Inc. and related stocks with our FREE daily email newsletter.